Linda Yaccarino, the former head of Elon Musk’s social media platform X, has been appointed as the new CEO of Miami-based telehealth company eMed. The appointment marks a significant shift for Yaccarino, who previously worked in marketing and advertising before joining X.
emed, which offers GLP-1 medications such as Wegovy and Ozempic, says Yaccarino’s experience will be crucial in expanding its national and global employer and government partnerships. The company aims to make safe, effective, and sustainable chronic care accessible through a digital-first experience.
Yaccarino believes the healthcare industry can be transformed by combining technology, lifestyle, and data to create new powerful ways of reaching consumers. eMed was founded during the pandemic in 2020 and has since pivoted to weight loss drugs.
Yaccarino’s tenure at X was marked by public relations crises, including concerns over antisemitic content and false claims about international conflicts. However, she remains unavailable for comment on her new role at eMed.
Source: https://edition.cnn.com/2025/08/05/business/linda-yaccarino-new-job-emed-ceo